WPC
MRVI icon

Wedmont Private Capital’s Maravai LifeSciences MRVI Stock Holding History

Wedmont Private Capital’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,539
Closed -$119K – 744
2024
Q4 		$119K Sell
24,539
-14,087
-36% -$90.6K 0.01% 691
2024
Q3 		$302K Buy
38,626
+119
+0.3% +$1.03K 0.02% 504
2024
Q2 		$344K Sell
38,507
-3,932
-9% -$33.9K 0.02% 453
2024
Q1 		$361K Buy
42,439
+5,242
+14% +$35.5K 0.03% 400
2023
Q4 		$256K Buy
37,197
+26,316
+242% +$170K 0.02% 468
2023
Q3 		$98.3K Buy
+10,881
New +$119K 0.01% 493

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedmont Private Capital's MRVI Position: Q1 2025 in Review

Wedmont Private Capital sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 24,539 shares — an estimated $119K sold.

Wedmont Private Capital first reported a position in MRVI in Q3 2023 and held it in 6 quarters. The position peaked at $361K in Q1 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • Wedmont Private Capital reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Wedmont Private Capital sold 24,539 Maravai LifeSciences shares in Q1 2025, an estimated $119K.
  • Wedmont Private Capital first reported a position in Maravai LifeSciences in Q3 2023 and held it in 6 quarters.
  • Wedmont Private Capital's Maravai LifeSciences position peaked at $361K in Q1 2024.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Wedmont Private Capital's 13F filing for Q1 2025, filed 14 Apr 2025.